The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical Studies

Anti-programmed cell death protein 1 (PD-1) monoclonal antibody therapy is becoming a standard treatment for advanced melanoma that produces durable responses and prolonged survival, but the prognosis of patients with liver metastases is still unsatisfactory. Here, we analyzed five clinical studies...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Wang, Xuan, Ji, Qing, Yan, Xieqiao, Lian, Bin, Si, Lu, Chi, Zhihong, Sheng, Xinan, Kong, Yan, Mao, Lili, Bai, Xue, Tang, Bixia, Li, Siming, Zhou, Li, Cui, Chuanliang, Guo, Jun
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7552942/
https://ncbi.nlm.nih.gov/pubmed/33117684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.546604
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares